Please login to the form below

Not currently logged in
Email:
Password:

Beta thalassemia

This page shows the latest Beta thalassemia news and features for those working in and with pharma, biotech and healthcare.

Bluebird bio pushes back commercial launch of Zynteglo due to COVID-19

Bluebird bio pushes back commercial launch of Zynteglo due to COVID-19

That delays also include its application to the US Food and Drug Administration (FDA) for its gene therapy for beta thalassemia LentiGlobin – which has already been approved in Europe with the

Latest news

More from news
Approximately 4 fully matching, plus 18 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics